Mental HealthICD-10: F60.3Uncommon in the general population but frequently seen in mental health services; more often diagnosed in women, though it affects all genders

Borderline Personality Disorder

Also known as: BPD, Emotionally unstable personality disorder

Borderline personality disorder (BPD) is a mental health condition characterized by intense and rapidly shifting emotions, an unstable sense of self, fear of abandonment, and turbulent relationships. People with BPD often feel emotions more intensely and for longer than others and may act impulsively, including self-harm, when overwhelmed. The condition usually becomes apparent in adolescence or early adulthood and is strongly linked to a combination of inherited emotional sensitivity and invalidating or traumatic early environments. BPD carries a great deal of stigma, yet it is highly treatable: specialized psychotherapies help most people reduce symptoms substantially, and many no longer meet the criteria for the diagnosis after several years of treatment.

Last updated November 10, 2026

Understanding Borderline Personality Disorder

Borderline personality disorder is a pattern, present since adolescence or early adulthood, of intense and fast-shifting emotions, an unstable sense of who you are, impulsive actions under distress and relationships that lurch between closeness and rupture, with a fear of being abandoned running underneath. Community surveys put it at about 1.5 to 3 percent of US adults, and it accounts for roughly 10 percent of people in outpatient psychiatric care and about 20 percent of psychiatric inpatients. Women make up about three-quarters of those diagnosed in clinics, but community surveys find rates nearly equal in men, who are more often labeled with antisocial traits or substance problems instead. Around 70 percent report childhood abuse, neglect or chronic invalidation, and twin studies put heritability near 40 to 55 percent, so most people arrive at the diagnosis with both a sensitive temperament and a history that taught them their feelings were unsafe. Self-harm occurs in 65 to 80 percent at some point, and suicide in roughly 3 to 10 percent across follow-up studies, which is why the condition is taken seriously.

The core problem is emotion regulation. Imaging studies show the amygdala, which flags threat, reacting more strongly and settling more slowly, with weaker engagement of the prefrontal regions that normally damp it down, so a frown or an unanswered text can produce a wave of fear or rage that peaks fast and takes hours to subside. In that state thinking narrows to all-or-nothing, the self feels empty or fragmented, and impulsive acts such as cutting, binge drinking or ending a relationship work in the short term because they interrupt unbearable arousal. The natural course is more hopeful than its reputation. In the McLean Study of Adult Development, which followed 290 inpatients with BPD for 16 years, 99 percent achieved a symptom remission lasting at least 2 years and 78 percent a remission of 8 years, with impulsive symptoms such as self-harm fading first and chronic emptiness and relationship anxiety lingering longest. Full recovery, meaning good work and relationships as well as symptom relief, was slower and reached by about half to 60 percent.

Psychotherapy is the treatment, and the evidence is strong enough that the 2024 American Psychiatric Association practice guideline and the NICE guideline both recommend a structured, BPD-specific therapy as first line and advise against medication as the primary treatment. Dialectical behavior therapy (DBT) is the best studied: in Linehan's 2006 trial of 101 women with recent suicidal behavior, DBT halved suicide attempts and cut emergency visits and admissions compared with therapy from community experts, and the 2020 Cochrane review of 75 trials (4,507 people) found DBT reduced self-harm and improved functioning with moderate effects. Mentalization-based treatment, schema therapy, transference-focused psychotherapy and general psychiatric management have each matched or approached DBT in head-to-head trials, so access and fit matter more than brand. No drug is approved for BPD anywhere; the 2022 Cochrane review of medication found only low-certainty, inconsistent benefits, yet more than 80 percent of people with BPD are prescribed psychiatric drugs and about 1 in 5 take four or more. Medication is reasonable for a clearly diagnosed co-occurring condition such as major depression, ADHD or PTSD.

Supplements are adjuncts at best, and nothing in a bottle teaches the skills that change its course. The one with real evidence is omega-3 fatty acids: a 2021 meta-analysis of 4 randomized trials in 137 people found that 1 to 2 g daily of EPA-rich fish oil produced a moderate reduction in overall BPD severity and in impulsivity and emotional reactivity, though not in depressive symptoms, over 8 to 12 weeks. N-acetylcysteine has a small open-label study in adolescents who self-harm and better trials in related compulsive behaviors, so it is a reasonable question to raise, not an answer. St John's wort, SAMe, saffron and lavender have trials in depression or anxiety but none in BPD, and St John's wort is a bad idea for anyone on an antidepressant or oral contraceptive. Ashwagandha, GABA, 5-HTP, magnesium, vitamin D and CBD have no BPD data at all, and 5-HTP combined with an SSRI risks serotonin syndrome. Regular exercise, consistent sleep and mindfulness practice, by contrast, have trial support for mood and impulse control and are built into DBT.

The most common mistake, made by patients and clinicians alike, is treating BPD as a medication problem and collecting prescriptions one crisis at a time. Each new drug is added in an emergency, few are ever stopped, and the result is sedation, weight gain and an unchanged pattern. The remedy is to find a therapist or program offering a BPD-specific treatment and to ask prescribers at each visit which medication could come off. The second mistake is waiting for the perfect therapy: a DBT skills group, a psychiatrist trained in general psychiatric management or a well-run day program all beat an 18-month wait list for full DBT. The third is hiding the diagnosis from loved ones out of shame; family programs such as Family Connections reduce burden and conflict. If you are thinking about suicide or have harmed yourself and cannot stay safe, call or text 988 in the US or go to an emergency department, and ask for a crisis plan to be written down before the next wave.

At a Glance

Common symptoms
Intense fear of abandonment and frantic efforts to avoid it, real or imagined, Unstable, intense relationships that swing between idealizing and devaluing, Unclear or shifting self-image and sense of identity
Main treatments
Dialectical behavior therapy (DBT), the most studied treatment, teaching emotion regulation and distress tolerance, Mentalization-based therapy, schema therapy, or transference-focused therapy as alternatives, Medication for specific coexisting symptoms such as depression or anxiety; no drug treats BPD itself
Category
Mental Health · Uncommon in the general population but frequently seen in mental health services; more often diagnosed in women, though it affects all genders
See a doctor if
Emotions feel unmanageable and are damaging relationships, work, or study

Symptoms

Intense fear of abandonment and frantic efforts to avoid it, real or imagined
Unstable, intense relationships that swing between idealizing and devaluing
Unclear or shifting self-image and sense of identity
Impulsive, potentially self-damaging behavior (spending, substance use, risky sex, reckless driving)
Recurrent self-harm or suicidal behavior or threats
Intense mood swings lasting hours to a few days
Chronic feelings of emptiness, inappropriate intense anger, or stress-related paranoia or dissociation

Causes

  • Genetic predisposition to emotional sensitivity and impulsivity
  • Childhood trauma, abuse, or neglect
  • An invalidating environment in which emotions were dismissed or punished
  • Differences in brain regions regulating emotion and impulse control
  • Early loss or unstable family relationships

Risk Factors

  • Family history of BPD or other mental illness
  • History of childhood abuse or neglect
  • Chronic emotional invalidation growing up
  • Unstable or chaotic early family life
  • Coexisting conditions such as depression, PTSD, or substance use

Diagnosis

  • Comprehensive psychiatric assessment of long-standing patterns in emotions, relationships, and behavior
  • Structured interviews or questionnaires for personality disorders
  • Assessment of coexisting conditions including mood disorders, PTSD, ADHD, and substance use
  • Careful evaluation of self-harm and suicide risk

Treatment

  • Dialectical behavior therapy (DBT), the most studied treatment, teaching emotion regulation and distress tolerance
  • Mentalization-based therapy, schema therapy, or transference-focused therapy as alternatives
  • Medication for specific coexisting symptoms such as depression or anxiety; no drug treats BPD itself
  • Crisis planning and short hospital stays when safety is at risk
  • Treatment of coexisting conditions such as PTSD or substance use
  • Supportive: skills practice between sessions, peer support groups, and involving family in education
  • Supportive: regular sleep, exercise, and avoiding alcohol and drugs, which worsen impulsivity and mood swings

Natural remedies for borderline personality disorder: what the evidence says

Ranked by the strength of human evidence for borderline personality disorder specifically. These sit alongside medical care, not in place of it.

  1. Omega-3

    Moderate evidence

    In the first trial, 30 women with BPD took 1 g of ethyl-EPA or placebo for 8 weeks and showed less aggression and depression on the active treatment. A 2014 trial of 43 people added 1.2 g EPA plus 0.9 g DHA to valproate for 12 weeks and found greater improvement in impulsivity, anger and self-harm. The 2021 meta-analysis of 4 trials (137 participants) found a moderate overall effect (standardized mean difference about 0.5) on symptom severity, driven by impulsivity and affect dysregulation, with no effect on depressive symptoms; the 2022 Cochrane review rated the evidence low certainty.

    Studied dose
    1 to 2 g daily of combined EPA and DHA with EPA predominant (for example 1 g EPA), with food, for at least 8 to 12 weeks before judging.
    Cautions
    Mild antiplatelet effect, so mention it if you take anticoagulants or have a bleeding disorder. Fishy aftertaste and loose stools are common; avoid with fish allergy, and keep doses under 3 g unless clinician-guided because of a small rise in atrial fibrillation risk seen in cardiology trials.
  2. N-Acetylcysteine (NAC)

    Preliminary evidence

    NAC modulates glutamate signaling, which is implicated in compulsive and impulsive behavior, and it has placebo-controlled evidence in trichotillomania and skin picking. In an open-label 8-week study of 35 adolescent girls with repeated non-suicidal self-injury, 1,200 to 2,400 mg daily significantly reduced the frequency of self-harm and depressive symptoms. There is no placebo-controlled trial in BPD, and placebo effects in self-harm studies are large, so this is a question for your prescriber rather than a recommendation.

    Studied dose
    600 mg twice daily, increased to 1,200 mg twice daily if tolerated, for 8 weeks, as in the pilot study.
    Cautions
    Nausea, heartburn and bloating are common; rare rashes. It can add to the blood-pressure-lowering and headache effects of nitroglycerin. Tell your prescriber, since NAC interacts with some psychiatric treatment plans and supplement products vary in quality.

What matters day to day

  • Fix a wake time and protect 7 to 9 hours in bed: a single night of sleep loss increases amygdala reactivity to negative images by about 60 percent in imaging studies, and insomnia affects most people with BPD, so sleep is the cheapest emotion-regulation tool available.
  • Treat alcohol and drugs as symptom amplifiers, not relief: about half of people with BPD develop a substance use disorder, alcohol doubles impulsive self-harm risk on the night it is used, and therapies work measurably better when use is reduced.
  • Use a physical reset when a wave hits, such as holding your face in cold water for 30 seconds or paced breathing at 6 breaths a minute: these DBT skills trigger the dive reflex and slow the heart within a minute, which is faster than any pill.
  • Move for 30 minutes most days: aerobic exercise reduces anger, depression and rumination in trials of mood disorders, and a regular session gives the day a structure that reduces the empty hours when distress builds.
  • Write a crisis plan with your clinician and keep it on your phone: warning signs, skills to try, people to call, the 988 line, and removing means such as stockpiled medication, which cuts suicide deaths more reliably than any other single step.
  • Eat at regular times: hunger and blood sugar dips sharpen irritability and impulsivity, and skipped meals are a common, overlooked trigger for the evening crises that many people with BPD describe.

Prevention

  • Early intervention for adolescents showing emerging symptoms
  • Supportive, validating parenting and family environments
  • Treating childhood trauma and its effects promptly
  • Learning emotion-regulation skills early, before patterns become entrenched
  • Avoiding substance misuse, which intensifies symptoms

When to See a Doctor

  • Emotions feel unmanageable and are damaging relationships, work, or study
  • You are self-harming or having suicidal thoughts (seek urgent help)
  • Impulsive behavior is putting you at risk
  • You experience episodes of feeling detached from yourself or reality
  • A loved one is concerned about repeated crises or relationship turmoil

Frequently Asked Questions

References

  1. Linehan MM, Comtois KA, Murray AM, et al.. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry (2006)
  2. Storebo OJ, Stoffers-Winterling JM, Vollm BA, et al.. Psychological therapies for people with borderline personality disorder. Cochrane Database of Systematic Reviews (2020)
  3. Stoffers-Winterling JM, Storebo OJ, Pereira Ribeiro J, et al.. Pharmacological interventions for people with borderline personality disorder. Cochrane Database of Systematic Reviews (2022)
  4. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice GM. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study. American Journal of Psychiatry (2012)
  5. Karaszewska DM, Ingenhoven T, Mocking RJT. Marine omega-3 fatty acid supplementation for borderline personality disorder: a meta-analysis. Journal of Clinical Psychiatry (2021)
  6. Zanarini MC, Frankenburg FR. Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. American Journal of Psychiatry (2003)
  7. Cullen KR, Klimes-Dougan B, Westlund Schreiner M, et al.. N-acetylcysteine for nonsuicidal self-injurious behavior in adolescents: an open-label pilot study. Journal of Child and Adolescent Psychopharmacology (2018)
  8. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Borderline Personality Disorder (2024)
  9. National Institute for Health and Care Excellence. Borderline personality disorder: recognition and management (CG78) (2009)
  10. National Institute of Mental Health. Borderline Personality Disorder (2024)View source

Related Conditions

Have questions about Borderline Personality Disorder?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.